These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2820742

  • 21. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD, Sharkey RM, Haywood L, Natale AM, Wong GY, Siegel JA, Kennel SJ, Goldenberg DM.
    Cancer Res; 1992 Nov 01; 52(21):6036-44. PubMed ID: 1394228
    [Abstract] [Full Text] [Related]

  • 22. Gamma-detecting probe and autoradiographic studies of radiolabeled antibody B72.3 in CX-1 colon xenografts.
    Sampsel JW, Hinkle G, Nieroda C, Ignaszewski J, Thurston M, Martin EW.
    J Surg Oncol; 1990 Dec 01; 45(4):242-9. PubMed ID: 2250474
    [Abstract] [Full Text] [Related]

  • 23. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
    Buchsbaum DJ, Wahl RL, Normolle DP, Kaminski MS.
    Cancer Res; 1992 Dec 01; 52(23):6476-81. PubMed ID: 1423295
    [Abstract] [Full Text] [Related]

  • 24. Dosimetric comparison of bolus and continuous injections of CC49 monoclonal antibody in a colon cancer xenograft model.
    Roberson PL, Dudek S, Buchsbaum DJ.
    Cancer; 1997 Dec 15; 80(12 Suppl):2567-75. PubMed ID: 9406711
    [Abstract] [Full Text] [Related]

  • 25. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
    Gerretsen M, Schrijvers AH, van Walsum M, Braakhuis BJ, Quak JJ, Meijer CJ, Snow GB, van Dongen GA.
    Br J Cancer; 1992 Sep 15; 66(3):496-502. PubMed ID: 1520586
    [Abstract] [Full Text] [Related]

  • 26. Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibody.
    Milenic D, Garmestani K, Dadachova E, Chappell L, Albert P, Hill D, Schlom J, Brechbiel M.
    Cancer Biother Radiopharm; 2004 Apr 15; 19(2):135-47. PubMed ID: 15186593
    [Abstract] [Full Text] [Related]

  • 27. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
    Colapinto EV, Zalutsky MR, Archer GE, Noska MA, Friedman HS, Carrel S, Bigner DD.
    Cancer Res; 1990 Mar 15; 50(6):1822-7. PubMed ID: 2407345
    [Abstract] [Full Text] [Related]

  • 28. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM, Wulst E, Radetzky S, Blumenthal RD, Dunn RM, Gratz S, Rave-Fränk M, Schmidberger H, Raue F, Becker W.
    Cancer Res; 1997 Dec 01; 57(23):5309-19. PubMed ID: 9393755
    [Abstract] [Full Text] [Related]

  • 29. Localization and imaging of radiolabeled monoclonal antibodies against colorectal carcinoma in tumor-bearing nude mice.
    Buchsbaum D, Lloyd R, Juni J, Wollner I, Brubaker P, Hanna D, Spicker J, Burns F, Steplewski Z, Colcher D.
    Cancer Res; 1988 Aug 01; 48(15):4324-33. PubMed ID: 3390828
    [Abstract] [Full Text] [Related]

  • 30. Potentiation of radioimmunotherapy with response-selective peptide agonist of human C5a.
    Kurizaki T, Okazaki S, Sanderson SD, Colcher D, Enke CA, Tempero MA, Baranowska-Kortylewicz J.
    J Nucl Med; 2002 Jul 01; 43(7):957-67. PubMed ID: 12097469
    [Abstract] [Full Text] [Related]

  • 31. Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
    Behr TM, Sgouros G, Vougiokas V, Memtsoudis S, Gratz S, Schmidberger H, Blumenthal RD, Goldenberg DM, Becker W.
    Int J Cancer; 1998 May 29; 76(5):738-48. PubMed ID: 9610734
    [Abstract] [Full Text] [Related]

  • 32. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG, Verschraegen CF, Murray JL, Kudelka AP, Gano J, Cheung L, Kavanagh JJ.
    Clin Cancer Res; 1999 May 29; 5(5):953-61. PubMed ID: 10353726
    [Abstract] [Full Text] [Related]

  • 33. Single-Dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using 131I-labeled multivalent CC49 single-chain fvs.
    Goel A, Augustine S, Baranowska-Kortylewicz J, Colcher D, Booth BJ, Pavlinkova G, Tempero M, Batra SK.
    Clin Cancer Res; 2001 Jan 29; 7(1):175-84. PubMed ID: 11205906
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors.
    Boerman OC, Sharkey RM, Blumenthal RD, Aninipot RL, Goldenberg DM.
    Int J Cancer; 1992 May 28; 51(3):470-5. PubMed ID: 1592537
    [Abstract] [Full Text] [Related]

  • 38. Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype antibody in tumor-bearing nude mice.
    Sharkey RM, Boerman OC, Natale A, Pawlyk D, Monestier M, Losman MJ, Goldenberg DM.
    Int J Cancer; 1992 May 08; 51(2):266-73. PubMed ID: 1568794
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Quantitative autoradiographic evaluation of the influence of protein dose on monoclonal antibody distribution in human ovarian adenocarcinoma xenografts.
    Yang FE, Brown RS, Koral KF, Clavo AC, Jackson GA, Wahl RL.
    Cancer Immunol Immunother; 1992 May 08; 35(6):365-72. PubMed ID: 1394341
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.